INTRODUCTION {#S1}
============

In persons with advanced chronic kidney disease (CKD), the kidney has been known to atrophy\[[@R1]\], particularly the cortex\[[@R2]\]. Kidney volume has been recently suggested as a useful surrogate for kidney function in CKD patients\[[@R3]\]. Although these prior investigations establish an association of decreased kidney volume with decreased kidney function among patients with advanced CKD, the association of kidney volume with kidney function and CKD risk factors in patients with mild or no CKD is less clear. Indeed, some risk factors for CKD, namely obesity and diabetes, have been associated with increased kidney volume \[[@R4]--[@R6]\].

The relationship of kidney volume with normal aging has been uncertain. Relatively small studies in potential kidney donors have not found evidences of kidney volume decline with age by computed tomography (CT) scan, though few subjects over the age of 60 years were included\[[@R6], [@R7]\]. Conversely, imaging studies in populations with clinical indications for their CT scan and older adults do find a decline in kidney parenchymal volume with age \[[@R7]--[@R10]\]. The reasons for the discrepant findings are unclear. The cortex and medulla contain different nephron segments that may hypertrophy or atrophy in the setting of different CKD risk factors and markers. Separate analyses of cortical and medullary volumes focusing on the renal parenchyma (e.g., exclusion of sinus fat and the renal pelvis from volume calculations) may help clarify the clinical factors that associate with kidney parenchymal volume.

Because potential kidney donors undergo a standardized rigorous evaluation including a renal CT angiogram (CTA), they are useful for characterizing clinical-pathological correlations in a population not selected on disease \[[@R11]--[@R13]\]. While patients with known CKD and significant comorbidity are excluded from the donor evaluation, patients with subclinical disease (e.g., microalbuminuria) and some CKD risk factors (e.g., hypertension) often undergo evaluation. A unique benefit of contrast enhanced CT scanning is the ability to distinguish cortex from medulla. So the objective of this study was to accurately measure the cortical, medullary, and total parenchymal volume in a large sample of potential kidney donors and determine their association with age, kidney function and CKD risk factors.

RESULTS {#S2}
=======

Study sample {#S3}
------------

There were 1487 potential kidney donors with an analyzed CTA between 2000 and 2008 at the Mayo Clinic. Of these, 9 were excluded for diabetes (fasting glucose \> 126) \[[@R14]\], 24 were excluded for movement artifact, 103 were excluded for incomplete kidney coverage, 1 was excluded for scout image only (solitary kidney), and 7 were excluded for polycystic kidneys\[[@R15]\], leaving 1344 donors for the study sample. Of these, 1192 were segmented for bilateral kidney cortical volume and medullary volume. The remaining 152 potential donors only had segmentation for the total parenchymal volume due to inadequate cortical-medullary differentiation. [Table 1](#T1){ref-type="table"} lists the clinical characteristics for potential donors. Larger potential donors (male or higher BSA) tended to have inadequate cortical-medullary differentiation, likely due to more X-ray beam attenuation by surrounding tissue. Since body size is both a CKD risk factor and confounded with CT image quality \[[@R15]\], we did not exclude potential donors with inadequate cortical-medullary differentiation in our analyses of total parenchymal volume. As shown in [Table 2](#T2){ref-type="table"}, kidney volumes had a satisfactory inter- and intra-test reproducibility.

Kidney volume with age {#S4}
----------------------

The median kidney cortical volume among 1192 potential donors was 211 cc (10th--90th percentiles 157--268 cc). As shown in [Table 3](#T3){ref-type="table"} and [Figure 1a](#F1){ref-type="fig"}, men had larger kidney cortical volume than women (p\<0.01 for all age groups). Cortical volume and cortical volume per BSA progressively declined with age but more steeply after age 50 years ([Figure 1a, Figure 1b](#F1){ref-type="fig"}, [Table 4](#T4){ref-type="table"}). The rate of decline did not differ by gender (p=0.15, test for age × gender interaction). Cortical volume had a stronger correlation with BSA (r=0.62, p\<0.01) ([Online Figure a](#SD1){ref-type="supplementary-material"}) compared to BMI (r=0.29, p \< 0.01).

The median kidney medullary volume among 1192 potential donors was 80 cc (10th--90th percentiles 57--110 cc). As shown in [Table 3](#T3){ref-type="table"} and [Figure 1c](#F1){ref-type="fig"}, men had larger kidney medullary volume than women (p\<0.01 for all age groups). Medullary volume and medullary volume per BSA increased with age in men, while in women it increased with age until age 50 years with a subsequent decline ([Figure 1c, Figure 1d](#F1){ref-type="fig"}, [Table 4](#T4){ref-type="table"}). These changes differed by gender (p=0.009, test for age × gender interaction). Medullary volume had a stronger correlation with BSA (r=0.45, p\<0.01) ([Online Figure b](#SD1){ref-type="supplementary-material"}) compared to BMI (r=0.20, p\<0.01).

Kidney parenchymal volume was obtained through the sum of cortex and medulla volume or direct measurement for potential donors where inadequate cortical-medullary differentiation. The median kidney parenchymal volume among 1344 potential donors was 292 cc (10th--90th percentiles 225--373 cc). As shown in [Table 3](#T3){ref-type="table"} and [Figure 1e](#F1){ref-type="fig"}, men had larger kidney parenchymal volume than women (p\<0.01 for all age groups). Kidney parenchymal volume and parenchymal volume per BSA was relatively stable with age until age 50 years with a subsequent decline ([Figure 1e, Figure 1f](#F1){ref-type="fig"}, [Table 4](#T4){ref-type="table"}). These changes differed by gender (p=0.01, test for age × gender interaction). Parenchymal volume had stronger correlation with BSA (r=0.68, p\<0.01) ([Online Figure c](#SD1){ref-type="supplementary-material"}) than with BMI (r=0.36, p\<0.01).

Kidney volume with kidney function and CKD risk factors {#S5}
-------------------------------------------------------

As shown in [Table 5](#T5){ref-type="table"}, the independent predictors of increased cortical volume were younger age, male gender, increased measured glomerular filtration rate (mGFR), increased 24-h urine albumin, current smoker, increased BMI, increased serum glucose, and decreased HDL cholesterol. Increased cortical volume per BSA had similar independent associations with male gender, increased mGFR, increased 24-h urine albumin, current smoker and decreased HDL cholesterol. Age was not an independent predictor of cortical volume per BSA (even when modeling age as a linear spline with a knot at age 50 years with age × gender interaction terms). BMI was negatively associated with increased cortical volume per BSA but there is relatively strong correlation between BMI and BSA(r=0.66, p\<0.001).

Hyperfiltration (GFR \>130ml/min/1.73m^2^) was associated with cortical volume (48 cc larger, p\<0.001), even after age-gender-BSA adjustment (37 cc larger, p\<0.001). Albuminuria (24-hr urine albumin\>30mg) was associated with cortical volume (28 cc larger, p=0.004), even after age-gender-BSA adjustment (24 cc larger, p\<0.001). Obesity (BMI\>30 kg/ m^2^) was associated with cortical volume (25 cc larger, p\<0.001) even after age-gender adjustment (25cc larger, p\<0.001).

Kidney medullary volume correlated with GFR (r=0.20, p\<0.001), although the association was weaker compared to cortical volume (r=0.49, p\<.001). As shown in [Table 6](#T6){ref-type="table"}, the independent predictors of increased medullary volume were older age, male gender, increased mGFR, increased 24-h urine albumin, increased BMI, increased serum glucose, and decreased serum uric acid. Increased medullary volume per BSA had similar independent associations with older age, male gender, increased mGFR, increased 24-h urine albumin, increased serum glucose, and decreased serum uric acid. Uric acid was positively associated with increased medullary volume in unadjusted analysis due to the higher uric acid levels and larger medullary volumes in men compared to women.

Hyperfiltration was associated with medullary volume (9.5 cc larger, p=0.0002), even after age-gender-BSA adjustment (10.7cc larger, p\<0.001). Albuminuria was not associated with medullary volume (2.7 cc larger, p=0.46). Obesity was associated with medullary volume (8.4 cc larger, p\<0.001) even after age-gender adjustment (8.4cc larger, p\< 0.001).

Kidney parenchymal volume correlated with GFR (r=0.45, p\<0.001). As shown in [Table 7](#T7){ref-type="table"}, the independent predictors of increased parenchymal volume were male gender, increased mGFR, increased 24-h urine albumin, current smoker, increase BMI, increased serum glucose, decreased HDL cholesterol, and decreased serum uric acid. Older age was borderline associated with increased parenchymal volume in multivariate analysis. Increased parenchymal volume per BSA had similar associations with male gender, increased mGFR, increased 24-h urine albumin, and current smoker. Older age was statistically associated with increased kidney parenchymal volume per BSA in the multivariate analysis. Findings were similar using GFR in ml/min instead of GFR in ml/min/1.73 m^2^ in the multivariate analyses except that with adding BSA as a predictor to the model, BMI was not associated or was negatively associated with kidney volumes ([Online Table](#SD1){ref-type="supplementary-material"}).

Hyperfiltration was associated with kidney parenchymal volume (57cc larger, p\<0.0001) even after age-sex-BSA adjustment (49cc larger, p\<0.001). Albuminuria was associated with parenchymal volume (44cc larger, p\<0.001) even after age-sex-BSA adjustment (33cc larger, p\<0.001). Obesity was associated with kidney parenchymal volume (36cc larger, p\<0.001) even after age-gender adjustment (35cc larger, p\<0.001).

Kidney volume with renal cysts {#S6}
------------------------------

After age-sex-BSA adjustment, presence of any cortical cyst \>10mm in diameter was associated with medullary volume (4.5 cc larger, p=0.03) and kidney parenchymal volume (8.2 cc larger, p=0.05), but not cortical volume (4.9 cc larger, p=0.16), After age-sex-BSA adjustment, presence of any medullary cyst \>10mm in diameter was not statistically significantly associated with cortical volume (5.3 cc larger, p=0.23), medullary volume (3.0 cc larger, p=0.24), or kidney parenchymal volume (9.0 cc larger, p=0.10). Adding presence of any cyst \>10mm to the multivariate models did not substantively change any of the associations of kidney volumes with clinical characteristics.

Independence of GFR decline with age from kidney volume changes {#S7}
---------------------------------------------------------------

The decline in cortical volume per BSA (−4.7 cc/m^2^ per decade, p\<0.001) with age was largely attenuated after adjustment for GFR (−1.2 cc/m^2^ per decade, p=0.001) and no longer statistically significant with further adjustment for CKD risk factors (gender, 24-h urine albumin, current smoker, BMI, glucose, and HDL cholesterol). Alternatively, we assessed whether the decline in GFR with age was independent of kidney volumes. GFR declined with age by −6.8 (95% CI −6.0 to −7.6) ml/min/1.73 m^2^ per decade, and this decline changed with adjustment for cortical volume per BSA −4.2 (95% CI −3.4 to −5.0) ml/min/1.73 m^2^ per decade, medullary volume per BSA −7.6 (95% CI −6.8 to −8.4) ml/min/1.73 m^2^ per decade, or kidney parenchymal volume per BSA −5.2 (95% CI −4.6 to −5.8) ml/min/1.73 m^2^ per decade. The decline in GFR with age remained statistically significant with adjustment for cortical volume per BSA and the other CKD risk factors (gender, 24-h urine albumin, current smoker, BMI, glucose, and HDL cholesterol) −4.7 (95% CI --3.9 to --5.6) ml/min/1.73 m^2^ per decade. The impact of BSA adjustment on unstandardized GFR (ml/min) decline with age was minimal. GFR declined by −8.3 ml/min per decade unadjusted, by −7.5 ml/min per decade adjusted for BSA, by −4.3 ml/min per decade adjusted for cortical volume, and by −4.7 ml/min per decade adjusted for cortical volume and BSA.

DISCUSSION {#S8}
==========

This study separately characterized the clinical characteristics that associate with kidney cortex, medulla, and parenchymal volume in relatively healthy adults and found several novel findings. First, with older age, cortical volume progressively declined in both genders while medullary volume increased in men but only initially increased in women followed by a subsequent decline. Second, the age-related decline in cortical volume was dependent on the age-related decline in kidney function and CKD risk factors, but the age-related decline in GFR was only partially attenuated by the cortical volume decline and CKD risk factors. Third, cortical and medullary volume had different associations with CKD risk factors suggesting that hypertrophy or atrophy can differ between nephron segments in their interaction with CKD risk factors. Finally, while a decrease in cortical volume is often seen in advanced CKD, increased cortical volume may be an early marker of CKD risk since it associates with hyperfiltration and albuminuria.

Our results showed kidney cortical volume per BSA decreased with aging, and this was dependent on GFR decline, albuminuria, and increased CKD risk factors with older age. Underlying nephrosclerosis (glomerulosclerosis and tubular atrophy) may explain this association by leading to both cortical volume loss and GFR reduction \[[@R16], [@R17]\]. It was also evident that cortical volume decline only partially accounted for GFR decline with aging. Since nephrons unaffected by nephrosclerosis can hypertrophy and hyperfilter to compensate for sclerosed nephrons, GFR decline with age may not be fully reflected in the cortical volume decline with age \[[@R17]\].

Unlike cortical volume, medullary volume increased with age, except in women over the age of 50 years. The reason for this increase and the gender difference are not entirely clear. There are important functional and structural changes of medulla during aging and with kidney injury. Medullary fibrosis increases with age and hypertension\[[@R18]\]; renomedullary interstitial cells show antihypertensive action by secretion of prostaglandins \[[@R19]\]; and hypoxia of the medulla may increase susceptibility to acute and chronic renal injury\[[@R20]\]. Autopsy studies suggest medullary fibrosis increases with age throughout the medulla, but only the fibrosis in inner medulla associates with decreased kidney weight\[[@R18]\]. This may indicate hypertrophy or hyperplasia of nephron segments in the outer stripe of medulla. Alternatively, age-related global glomerulosclerosis is most severe in the superficial cortex. This may increase perfusion to the juxtamedullary nephrons with the longest loops of Henle that may hypertrophy and increase medullary volume\[[@R21]\]. Eventually, atrophy from nephrosclerosis could have a net effect of medullary volume loss, and this may occur earlier in women than in men. Women are known to have fewer nephrons than men \[[@R22], [@R23]\] and may have less compensatory reserve. Furthermore, this finding may be related to the post-menopausal loss of the protective effects of estrogen, which leads to loss of renal microvessels \[[@R24]\].

Another prior study also using potential kidney donors did not find kidney parenchymal volume to decline with age but few subjects older than 60 years were included\[[@R6]\]. Our data clarifies that while kidney parenchymal volume is stable with aging in younger adults, there is still a decline with age in the older adults who are ostensibly healthy. Further, the competing cortical volume decline and medullary volume increase with age explains why the total parenchymal volume changes little with age in younger adults even though cortical nephrosclerosis on renal biopsy occurs with aging even in young adults \[[@R16]\].

Our data suggested increased cortical volume may be an indicator and a pathway of early kidney injury since it associates with hyperfiltration and albuminuria. Diabetics are known to develop enlarged kidneys with hyperfiltration in early diabetic nephropathy \[[@R25]\]. This process may be more universal than just diabetes as evidenced by our findings in a non-diabetic population. Hypertension associates with hyperfiltration\[[@R26], [@R27]\], but our study did not find an association between increased kidney volume and blood pressure independent of other clinical characteristics. Prior studies associated current cigarette smoking with hyperfiltration and proteinuria, whereas past smokers did not have abnormal kidney function \[[@R28], [@R29]\]. Our study extends these findings by showing an increased kidney volume with current smoking, but not in past smokers. Obesity has been previously associated with increased kidney parenchymal volume\[[@R6]\] and hyperfiltration\[[@R30]--[@R32]\]. Glomerulomegaly is one of the common features of obesity related glomerulopathy\[[@R33]\]. The association of obesity with increased cortical volume indicates that obesity-related glomerulomegaly with tubular hypertrophy might contribute to the volume increase in cortex at the early kidney injury. Studies in subjects without kidney disease showed lower HDL cholesterol associated with hyperfiltration\[[@R34]\]. Our data of the association of lower HDL cholesterol with increased cortical volume suggest HDL cholesterol plays a protective role in the cortical changes of early CKD. Treatment of low HDL cholesterol level, together with smoking cessation and body weight control may help to prevent the increased cortical volume and underlying hypertrophy of nephrons that reflect early kidney injury.

Different from cortical volume per BSA, increased medullary volume per BSA independently associated with increased glucose and decreased serum uric acid. As a product of purine nucleotide cycle, production of uric acid is more active in medulla than in cortex \[[@R35]\]. Studies showed serum uric acid is elevated in CKD and may be a marker for CKD progression \[[@R36], [@R37]\]. Hyperuricemia may lead to more damage and atrophy in the segments of nephrons in medulla than in cortex. Renal medulla may be the predominant site of several hyperglycemia-induced alterations in biochemical cellular pathways \[[@R38]\] and glycogen is shunted into the synthesis of medullary glycosaminoglycans during anti-diuresis \[[@R39]\]. Indeed, changes in tubulointerstitial structures have been evident during the early stages in diabetes \[[@R40], [@R41]\]. Given the relatively healthy population in our study, the association of increased serum glucose with increased medullary volume, but not cortical volume, suggest that glucose-related structural changes in the medulla might precede those in the cortex.

While we excluded detected cysts from the measurement of cortical and medullary volume, small undetected cysts could potentially contribute to increased kidney volumes. Indeed, patients with cortical cysts did have an increase in their medullary and kidney parenchymal volumes, possibly due to undetected cysts. However, detectable cysts did not account for any of the association of kidney volumes with kidney function and CKD risk factors. Thus, it is unlikely that undetected cysts explain the associations between kidney volumes and clinical characteristics.

A limitation of this study was relatively few subjects ages 70 years and older since the study population was potential kidney donors. We did not control the hydration status of donors undergoing CTAs and hydration may potentially affect kidney volumes. However, these were all healthy adults without acute illness at the time of their CT scans and diuretic use (3.9% of donors) was not associated with cortical, medullary, or total parenchymal kidney volume (p≥0.15 for all). As a cross-sectional study, the temporal relationship between changes in kidney volume and changes in kidney function is unclear.

In conclusion, our study provides new insights in the association of kidney cortical and medullary volume with aging, kidney function, and CKD risk factors. Increased kidney volume associates with hyperfiltration, albuminuria, and CKD risk factors even among a relatively healthy population. Increased kidney volume may reflect underlying glomerulomegaly and tubular hypertrophy. The reasons for gender differences between age related changes in the cortex and medulla volumes requires further study. The clinical role, if any, of cortical volume or medullary volume in evaluating kidney health and risk for CKD deserves further exploration. Future work is also needed to understand the relationship between the macro-anatomy of the kidney with the micro-anatomy on renal biopsy.

METHODS {#S9}
=======

Study population {#S10}
----------------

This study was approved by the institutional review board at the Mayo Clinic, Rochester Minnesota. All potential kidney donors were identified from 2000 to 2008 at the Mayo Clinic and were included if they had research authorization in accordance with Minnesota State law \[[@R42]\]. Potential kidney donors underwent a renal CTA scan and a standardized laboratory and clinical evaluation \[[@R42]\]. Kidney function and CKD risk factors were obtained through abstraction of electronic charts at the time of the donor evaluation and prior to donor nephrectomy (if done).

Multidetector CT examination {#S11}
----------------------------

As described previously \[[@R15], [@R42]\], 4-channel MDCT scanner (Qxi; GE Medical Systems, [www3.gehealthcare.com/en](http://www3.gehealthcare.com/en)) with slice thickness of 1.25mm and 7.5 mm/rotation was used in 2000--2005 and 64-channel MDCT scanner (Sensation 64; Siemens Medical Solutions, [www.medical.siemens.com](http://www.medical.siemens.com)) with 64 × 0.6 collimation, a pitch of 1.2, and 23 mm/rotation was used in 2005--2008 to acquire CTA examinations. CT Images from the angiogram phase were downloaded into a local workstation for processing.

CT scan review and kidney volume measurement {#S12}
--------------------------------------------

We estimated the kidney cortical and medullary volume using software (ITK-SNAP version 1.1, [www.itksnap.org](http://www.itksnap.org), [Figure 2](#F2){ref-type="fig"}) \[[@R43]\] to semi-automatically segment the cortex and medulla from transverse images obtained during the angiogram (arterial) phase. Contrast enhancement from the arcuate artery to afferent arterioles defined the cortex. Segmentation was based on active contour evolution using an energy minimizing spline algorithm. Cortex and medulla were segmented separately by using appropriate intensity value thresholds to create a feature image. Automated segmentation was initiated by placing spherical bubbles on the feature image (cortex or medulla). Hand editing ensured exclusion of any non-parenchymal regions, including sinus fat, cysts, kidney stones, scars or vessels missed by the software. Kidney volumes were measured in a random order by a trained imaging technologist masked to other characteristics of the donor. Images with movement artifact, polycystic kidneys, or incomplete kidneys in the imaging window were excluded. While the volumes measured excluded detectable cysts, the presence of any cortical or medullary cyst greater than 10 mm in diameter was specifically determined as described elsewhere \[[@R15]\]. For contrast images with inadequate cortex from medulla differentiation, full kidney segmentation with exclusion of sinus fat, cysts and other non-parenchymal tissues was performed and kidney parenchymal volume was measured directly.

Clinical and laboratory evaluation of potential kidney donors {#S13}
-------------------------------------------------------------

All potential kidney donors underwent a prescreening by a transplant nurse on a telephone interview before the clinic visit \[[@R15], [@R42]\] to exclude disorders that would preclude the donation (e.g., known CKD, diabetes, or cardiovascular disease). The remaining potential donors underwent a pre-scheduled battery of tests and evaluations over a 2-day period. These included a contrast enhanced abdominal CT scan, iothalamate clearance measurement (GFR in ml/min/1.73 m^2^), 24-hour urine albumin excretion, and CKD risk factors. These CKD risk factors were mostly components of metabolic syndrome and included blood pressure (BP), serum glucose, total cholesterol, LDL cholesterol, HDL cholesterol and uric acid. Body mass index (BMI) and body surface area (BSA) were calculated from height and weight \[[@R44], [@R45]\]. Obesity was defined as BMI \>30 kg/m2. Hypertension was defined as use of antihypertensive therapy for high blood pressure or systolic blood pressure ≥140 mm Hg or diastolic blood pressure ≥90 mm Hg at the initial evaluation. Hyperfiltration was defined by GFR\>130ml/min/1.73m2 and albuminuria was defined by 24-h urine albumin excretion \> 30 mg.

Reproducibility of kidney volume measurements {#S14}
---------------------------------------------

Occasionally potential kidney donors will undergo two separate evaluations as they may not be selected for the first kidney donation and the recipient may require another allograft. We searched the medical record of all our potential kidney donors to identify those with two pre-donation CT scans. The cortex and medulla were segmented for each of the two CT Scans and compared (inter-test CV). Finally we had two imaging technologists independently segment the same CT images (intra-test CV).

Statistical analysis {#S15}
--------------------

Cortical and medullary volumes were summed between both kidneys and kidney parenchymal volume was the sum of cortical and medullary volume. Scatter plots were generated to explore the relationship of kidney volumes with age, kidney function, and CKD risk factors. Linear regression models were used to identify which of these clinical characteristics associated with cortex, medulla, or whole parenchymal kidney volume. A linear spline with a knot at age 50 years was used to determine whether age related changes in kidney volumes differed between younger and older adults. Multivariate models assessed independence of clinical characteristics that associated with kidney volumes. Age × gender interaction was also assessed. Only clinical characteristics that associated with kidney volume in the univariate analysis were included in the multivariate models, except when redundant. Independent predictors for kidney volume were also assessed for their associations with kidney volume per BSA. The relationship between kidney cysts and non-cyst parenchymal volume were analyzed in separate models. All statistical analyses were performed using JMP, version 9.0 (SAS institute, [www.jmp.com](http://www.jmp.com)).
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###### 

Characteristics of potential kidney donors with contrast enhanced CT imaging.

  -----------------------------------------------------------------------------------------------------------------------------------------------------------
  Characteristic                               Potential donors with adequate\       Potential donors with inadequate cortical-\
                                               cortical-medullary differentiation\   medullary differentiation (n=152)\
                                               (n=1192) Mean ± SD or N (%)           Mean ± SD or N (%)
  -------------------------------------------- ------------------------------------- ------------------------------------------------------------------------
  **Demographic**                                                                    

  Age, y                                       44±12                                 45±12

  Over age 60 years                            118(10%)                              16(11%)

  Men                                          477(40%)                              82(54%) [\*](#TFN2){ref-type="table-fn"}

  White                                        1064(89%)                             138(91)

  Body surface area, m^2^                      1.9±0.2                               2.0±0.3 [\*](#TFN2){ref-type="table-fn"}

  **Kidney function**                                                                

  mGFR, ml/min/1.73m^2^                        102±19                                102±19

  Hyperfiltration, mGFR \>130ml/min/1.73m^2^   85(7.3%)                              13(8.8%)

  24-h urine albumin excretion, mg             7.2±15                                8.2±9.7

  Albuminuria, 24-h urine albumin \>30mg       35(3%)                                7(5%)

  **CKD risk factors**                                                               

  Current smoker                               244(20%)                              28(18%)

  Past smoker                                  281(24%)                              28(19%)

  BMI, kg/m^2^                                 28.3 ±5.3                             29.2±6.9

  Obesity, BMI\>30kg/m^2^                      402(34%)                              54(36%)

  Systolic BP, mmHg                            124±15                                126±17

  Diastolic BP, mmHg                           74±10                                 75±10

  Hypertension                                 176(15%)                              18(12%)

  Serum glucose, mg/dl                         95±8                                  95±10

  Total cholesterol, mg/dl                     199±39                                193±36

  HDL cholesterol, mg/dl                       57±17                                 53±13 [\*](#TFN2){ref-type="table-fn"}[†](#TFN3){ref-type="table-fn"}

  LDL cholesterol, mg/dl                       116±33                                115±32

  Uric acid, mg/dl                             5.3±1.3                               5.5±1.4

  **Renal Cysts**                                                                    

  Any cortical cyst \>10mm in diameter         96(8%)                                21(14%)[\*](#TFN2){ref-type="table-fn"}[†](#TFN3){ref-type="table-fn"}

  Any medullary cyst \>10mm in diameter        55(5%)                                9(6%)
  -----------------------------------------------------------------------------------------------------------------------------------------------------------

Note:

p\<0.05 by Oneway Anova test or Fisher exact test.

p\>0.05 with age-gender-BSA adjustment.

Abbreviations: BSA=body surface area; BMI=body mass index; BP=blood pressure; HDL=high-density lipoprotein; LDL=low-density lipoprotein; mGFR =measured glomerular filtration rate.

###### 

The median inter-test coefficient of variation (CV) of kidney volume measurements in 23 potential kidney donors who underwent a second contrast-enhanced CT scan (a mean 2.4 years apart) and median intra-test CV of kidney volume measurements in 24 potential donors by two different imaging technologists.

                      Kidney parenchymal volume   Cortical volume   Medullary volume
  ------------------- --------------------------- ----------------- ------------------
  **Inter-test CV**   2.9%                        6.2%              6.9%
  **Intra-test CV**   3.7%                        2.4%              3.6%

###### 

The median (10%, 90%) kidney cortical, medullary volume and kidney parenchymal volume (cc) among potential kidney donors by age group.

  Age group                    Cortical volume   Medullary volume   Parenchymal volume                                 
  ---------------------------- ----------------- ------------------ -------------------- ------------- --------------- ---------------
  **Overall** (n=1184--1334)   190(151, 243)     234(189, 295)      76(55, 99)           86(64, 120)   269(213, 339)   325(267, 402)
  **18--29y** (n=157--170)     204(161, 250)     244(190, 300)      72(50, 91)           77(57, 111)   272(224, 343)   322(263, 401)
  **30--39y** (n=308--349)     200(157, 253)     241(200, 295)      76(57, 106)          82(61, 112)   283(224, 351)   331(271, 397)
  **40--49y** (n=354--401)     193(154, 245)     240(188,294)       79(54, 100)          88(64, 127)   272(219, 340)   335(264, 416)
  **50--59y** (n=255--290)     180(146, 225)     218(186,297)       78(57, 102)          91(67, 125)   262(212, 325)   321(271, 404)
  **60--69y (n=110--124)**     163(133, 203)     207(172,274)       70(54, 92)           96(77,126)    230(196, 285)   307(260, 405)

###### 

Change in kidney cortical, medullary, and parenchymal volume by age.

  ---------------------------------------------------------------------------------------------------------------------------------------------------------------
  Kidney Volumes                   Age \< 50 years                    Age ≥ 50 years                     Test for change in slope before\
                                                                                                         and after age 50 years[\*](#TFN5){ref-type="table-fn"}
  -------------------------------- ---------------------------------- ---------------------------------- --------------------------------------------------------
  **Cortical Volume**              **cc per decade (p-value)**        **cc per decade (p-value)**        **p-value**

    Women                          −5.6(0.006)                        −17.7(\<0.0001)                    0.002

    Men                            −4.5(0.07)                         −17.9(0.004)                       0.04

  **Cortical volume per BSA**      **cc/m^2^ per decade (p-value)**   **cc/m^2^ per decade (p-value)**   **p-value**

    Women                          −3.7(0.0002)                       −7.8(\<0.0001)                     0.04

    Men                            −3.2(0.002)                        −9.2(0.001)                        0.07

  **Medullary volume**             **cc per decade (p-value)**        **cc per decade (p-value)**        **p-value**

    Women                          2.8(0.008)                         −6.1(0.006)                        0.0001

    Men                            5.1(0.0004)                        0.7(0.83)                          0.25

  **Medullary volume per BSA**     **cc/m^2^ per decade (p-value)**   **cc/m^2^ per decade (p-value)**   **p-value**

    Women                          1.4(0.01)                          −2.6(0.04)                         0.003

    Men                            2.0(0.0006)                        0.2(0.88)                          0.41

  **Parenchymal volume**           **cc per decade (p-value)**        **cc per decade (p-value)**        **p-value**

    Women                          −2.7(0.32)                         −22.6(\<0.001)                     0.0002

    Men                            1.4(0.68)                          −22.7(0.002)                       0.004

  **Parenchymal volume per BSA**   **cc/m^2^ per decade (p-value)**   **cc/m^2^ per decade (p-value)**   **p-value**

    Women                          −2.2(0.07)                         −9.8(\<0.001)                      0.005

    Men                            −0.8(0.51)                         −10.3(0.0008)                      0.01
  ---------------------------------------------------------------------------------------------------------------------------------------------------------------

Based on modeling age as a linear spline with a knot at age 50 years.

###### 

Predictors of kidney cortical volume and cortical volume per body surface area (BSA) among 1192 potential donors.

  Characteristics                                Cortical volume   Cortical volume /BSA                                            
  ---------------------------------------------- ----------------- ---------------------- ------ --------- ------ --------- ------ ---------
  [\*](#TFN7){ref-type="table-fn"}**Age, 10y**   −10.5             \<.0001                −2.3   0.009     −4.7   \<.0001   −0.7   0.09
  **Male**                                       44.8              \<.0001                34.9   \<.0001   8.6    \<.001    5.0    \<.0001
  **GFR, SD**                                    21.9              \<.0001                18.7   \<.0001   10.7   \<.0001   9.8    \<.0001
  **24 h urine albumin, doubling**               5.1               \<.0001                2.4    \<.0001   1.7    \<.0001   1.0    0.0002
  **Current smoker**                             15                \<.0001                9.9    \<.0001   9.3    \<.0001   6.3    \<.0001
  **Past smoker**                                1.0               0.73                   \-     \-        \-     \-        \-     \-
  **BMI, SD**                                    15                \<.0001                12.4   \<.0001   −0.6   0.24      −1.2   0.009
  **Diastolic BP, SD**                           5.1               \<.0001                1.3    0.17      \-     \-        \-     \-
  **Serum glucose, SD**                          7.6               \<.0001                2.6    0.01      0.3    0.65      0.8    0.13
  **Total cholesterol, SD**                      −2.4              0.06                   \-     \-        \-     \-        \-     \-
  **HDL cholesterol, SD**                        −16.2             \<.0001                −3.4   0.001     −3.1   \<.0001   −1.4   0.003
  **LDL cholesterol, SD**                        1.5               0.24                   \-     \-        \-     \-        \-     \-
  **Serum uric acid, SD**                        13.7              \<.0001                0.24   0.83      \-     \-        \-     \-

β indicates the change in volume (cc) with characteristic.

Multivariate associations were not substantively different with age modeled as a linear spline with a knot at 50 years with age × gender interaction terms.

###### 

Predictors of kidney medullary volume and medullary volume per body surface area (BSA) among 1192 potential donors.

  Characteristics                                Medullary volume   Medullary volume /BSA                                            
  ---------------------------------------------- ------------------ ----------------------- ------ --------- ------ --------- ------ ---------
  [\*](#TFN9){ref-type="table-fn"}**Age, 10y**   1.6                0.002                   3.7    \<.0001   1.1    \<.0001   2.2    \<0.001
  **Male**                                       11.9               \<.0001                 13.7   \<.0001   0.4    0.43      1.9    0.005
  **GFR, SD**                                    4.3                \<.0001                 5.4    \<.0001   2.0    \<.0001   2.9    \<.0001
  **24 h urine albumin, doubling**               1.2                0.003                   0.9    0.01      0.3    0.09      0.4    0.02
  **Current smoker**                             2.2                0.14                    \-     \-        \-     \-        \-     \-
  **Past smoker**                                2.8                0.05                    1.1    0.41      \-     \-        \-     \-
  **BMI, SD**                                    4.4                \<.0001                 4.9    \<.0001   −1.0   0.0006    −0.5   0.09
  **Diastolic BP, SD**                           2.1                0.0005                  0.3    0.66      \-     \-        \-     \-
  **Serum glucose, SD**                          4.4                \<.0001                 1.7    0.01      0.9    0.004     0.7    0.04
  **Total cholesterol, SD**                      −0.7               0.26                    \-     \-        \-     \-        \-     \-
  **HDL cholesterol, SD**                        −2.2               0.0002                  0.3    0.67      \-     \-        \-     \-
  **LDL cholesterol, SD**                        −0.1               0.84                    \-     \-        \-     \-        \-     \-
  **Serum uric acid, SD**                        1.7                0.005                   −3.1   \<.0001   −1.7   \<.0001   −1.9   \<.0001

β indicates the change in volume (cc) with characteristic.

Multivariate associations were not substantively different with age modeled as a linear spline with a knot at 50 years with age × gender interaction terms.

###### 

Predictors of kidney parenchymal volume and parenchymal volume per body surface area (BSA) among 1344 potential donors.

  Characteristics                                 Kidney parenchymal volume   Kidney parenchymal volume /BSA                                             
  ----------------------------------------------- --------------------------- -------------------------------- ------ --------- ------ ---------- ------ ---------
  [\*](#TFN11){ref-type="table-fn"}**Age, 10y**   −8.6                        \<.0001                          2.2    0.05      −3.5   \<0.0001   1.7    0.0008
  **Male**                                        59.5                        \<.0001                          51.5   \<.0001   9.5    \<.0001    7.9    \<.0001
  **GFR, SD**                                     26.9                        \<.0001                          24.7   \<.0001   12.9   \<.0001    12.8   \<.0001
  **24 h urine albumin, doubling**                8.1                         \<.0001                          4.4    \<.0001   2.4    \<.0001    1.9    \<.0001
  **Current smoker**                              16.9                        \<.0001                          12.2   \<.0001   11.0   \<.0001    7.9    \<.0001
  **Past smoker**                                 4.6                         0.24                             \-     \-        \-     \-         \-     \-
  **BMI, SD**                                     22.0                        \<.0001                          19.4   \<.0001   −0.8   0.20       −1.0   0.07
  **Diastolic BP, SD**                            9.0                         \<.0001                          1.2    0.31      \-     \-         \-     \-
  **Serum glucose, SD**                           11.5                        \<.0001                          2.9    0.03      0.9    0.19       0.83   0.16
  **Total cholesterol, SD**                       −3.1                        0.052                            \-     \-        \-     \-         \-     \-
  **HDL cholesterol, SD**                         −20.4                       \<.0001                          −3.0   0.02      −2.5   \<0.001    0.17   0.75
  **LDL cholesterol, SD**                         1.7                         0.29                             \-     \-        \-     \-         \-     \-
  **Serum uric acid, SD**                         17                          \<.0001                          −2.9   0.04      −0.8   0.21       −1.1   0.06

β indicates the change in volume (cc) with characteristic.

Multivariate associations were not substantively different with age modeled as a linear spline with a knot at 50 years with age × gender interaction terms.
